- Investing Ideas
- Egyptian Pharmaceuticals & Biotech Sustainable Track Record
Egyptian Pharmaceuticals & Biotech Sustainable Track Record
Results
6
Companies which have reinvested earnings to sustain 10% yearly growth over 5 years.
6 companies
Arab Drug
Market Cap: ج.م3.0b
Engages in the manufacture and sale of pharmaceutical products.
ADCI
ج.م253.12
7D
7.8%
1Y
86.5%
Alexandria For Pharmaceuticals & Chemical Industries
Market Cap: ج.م6.2b
Operates as a pharmaceutical company in Egypt.
AXPH
ج.م1,233.15
7D
2.1%
1Y
121.5%
Memphis Pharmaceuticals & Chemical Industries
Market Cap: ج.م6.1b
Engages in the research, development, manufacture, marketing, and distribution of pharmaceutical products for human and veterinary use in Egypt and internationally.
MPCI
ج.م269.00
7D
11.8%
1Y
206.3%
EI- Nile for Pharmaceuticals and Chemical Industries
Market Cap: ج.م11.5b
Develops, produces, and sells pharmaceutical products in Egypt.
NIPH
ج.م229.98
7D
24.4%
1Y
272.0%
Egyptian International Pharmaceutical Industries
Market Cap: ج.م15.3b
Manufactures and sells pharmaceutical ampoules in Egypt and internationally.
PHAR
ج.م90.70
7D
4.9%
1Y
74.6%
Kahira Pharmaceuticals & Chemical Industries
Market Cap: ج.م7.0b
Manufactures, packages, distributes, and trades in pharmaceutical products in Egypt and internationally.
CPCI
ج.م471.11
7D
8.8%
1Y
142.5%